IMNM vs MSFT: Which Stock is Better?
Side-by-side comparison of Immunome Inc and Microsoft Corporation in 2026
IMNM
Immunome Inc
$27.71
MSFT
Microsoft Corporation
$498.10
Key Metrics Comparison
| Metric | IMNM | MSFT | Winner |
|---|---|---|---|
| Market Cap | $2.47B | $3.71T | MSFT |
| P/E Ratio | N/A | 33.89 | IMNM |
| EPS (TTM) | $N/A | $14.08 | MSFT |
| Revenue Growth | 69.8% | 18.4% | IMNM |
| Gross Margin | 0.0% | 67.9% | MSFT |
Analyze IMNM
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is IMNM or MSFT a better investment?
Comparing IMNM and MSFT: Immunome Inc has a market cap of $2.47B while Microsoft Corporation has $3.71T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between IMNM and MSFT?
IMNM (Immunome Inc) and MSFT (Microsoft Corporation) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: IMNM or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: IMNM or MSFT?
IMNM has higher revenue growth at 69.8% vs 18.4% for MSFT.
Which company is more profitable: IMNM or MSFT?
Microsoft Corporation (MSFT) has higher gross margins at 67.9% compared to 0.0% for IMNM.
Which is the larger company: IMNM or MSFT?
Microsoft Corporation (MSFT) is larger with a market cap of $3.71T compared to $2.47B for IMNM.
Should I buy IMNM or MSFT in 2026?
Both IMNM and MSFT have investment merit. IMNM trades at $27.71 while MSFT trades at $498.10. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between IMNM and MSFT stock?
Key differences: Market Cap ($2.47B vs $3.71T), P/E Ratio (N/A vs 33.9x), Revenue Growth (69.8% vs 18.4%), Gross Margin (0.0% vs 67.9%).
Should I buy IMNM or MSFT in 2026?
The choice between IMNM and MSFT depends on your investment goals. IMNM shows higher revenue growth (69.8%). MSFT has better margins (67.9%). Consider your risk tolerance and time horizon.
What is the market cap comparison between IMNM and MSFT?
IMNM (Immunome Inc) has a market cap of $2.47B, while MSFT (Microsoft Corporation) has a market cap of $3.71T. MSFT is the larger company by market value.